MM
Marion McCourt (EVP Commercial) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Regeneron Pharmaceuticals, Inc. (REGN). The largest single filing was $984K of REGN (1,132 sh × $869.43, as filed), executed Oct 30. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$984K
shares × price, as filed
Last traded
Oct 30
Filed Nov 3
Median ADV $702.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $984K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
REGNRecent filings
REGNSALE
Regeneron Pharmaceuticals, Inc.
View filing →
$984K1,132 sh × $869.43
Exec Oct 30
Filed Nov 3 · 4:02 PM ET REGNSALE Regeneron Pharmaceuticals, Inc. View filing → $845K
1,000 sh × $844.61
Exec Nov 1 2024
Filed Nov 5 2024 · 5:30 PM ET